(Q48183074)

9 February 2018

title

Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo (English)

1 reference

9 February 2018

author

Eliyahu Dremencov

2

1 reference

9 February 2018

author name string

Gur E

1

1 reference

9 February 2018

Lerer B

3

1 reference

9 February 2018

Newman ME

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

9 February 2018

European Journal of Pharmacology

published in

1 reference

9 February 2018

volume

372

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

17-24

1 reference

9 February 2018

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

(-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Current advances and trends in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: modulation by pindolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Autoreceptor Antagonists Enhance the Effect of the Reuptake Inhibitor Citalopram on Extracellular 5-HT: this Effect Persists After Repeated Citalopram Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effect of 5-HT1A Receptor Antagonists on Citalopram-induced Increase in Extracellular Serotonin in the Frontal Cortex, Striatum and Dorsal Hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effects of imipramine on raphe nuclei and prefrontal cortex extracellular serotonin levels in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900164-8

10.1016/S0014-2999(99)00164-8

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018